- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Anne L. Schwartz Explains Data on Newly-Eligible Medicaid Enrollees
Anne L. Schwartz, PhD, executive director of the Medicaid and CHIP Payment and Access Commission, explains the core messages of new data on average spending for new Medicaid enrollees.
Anne L. Schwartz, PhD, executive director of the Medicaid and CHIP Payment and Access Commission, explains the core messages of new data on average spending for new Medicaid enrollees.
Transcript
In December, MACSTATS included, for the first time, state-by-state enrollment and benefit spending for adults who became eligible for Medicaid under the Patient Protection and the Affordable Care Act (ACA). Can you explain the key takeaways?
We don’t have a pre-ACA information on this population because they were not covered under the Medicaid program. So, we are pleased to have for the first time data at the state level of what the average spending for these enrollees is. There are really 2 core messages. One is there is a lot of variation across state in what per enrollee spending is for the new adult group and some of that reflects differences in prices across geographic areas. It’s very expensive to provide care in Alaska less so than in other states. That’s similar to what you see in other aspects of the program.
The other thing that you see is that spending per enrollee for the new adult group is in practically every state much lower than spending on average for all the other Medicaid enrollees and that is perhaps not a surprising finding because much of the Medicaid population is sick, chronic conditions, significant disabilities, and therefore use a considerable amount of medical long-term services and supports.
Could On-Body Delivery of Isatuximab Bring More Competition to Anti-CD38 Myeloma Treatment?
June 6th 2025Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration. Patients overwhelmingly preferred the hands-free delivery option.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Zanubrutinib Shows Durable Benefit for High-Risk CLL/SLL at 5 Years in SEQUOIA Trial
June 6th 2025Zanubrutinib showed long-term efficacy in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and deletion of the 17p chromosome, with progression-free survival similar to patients without high-risk disease characteristics.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Real-World Data Support Luspatercept vs ESAs for Anemia in Lower-Risk MDS
June 5th 2025Patients with myelodysplastic syndrome (MDS) who received luspatercept showed greater hemoglobin gains and transfusion independence compared with erythropoiesis-stimulating agents (ESAs) in a real-world analysis.
Read More
At EHA 2025, Hematology Discussions Will Stretch Across Lifespans and Locations
June 5th 2025The 2025 European Hematology Association (EHA) Congress, convening virtually and in Milan, Italy, from June 12 to June 15, 2025, will feature a revamped program structure for the meeting’s 30th anniversary while maintaining ample opportunities to network, debate, and absorb practice-changing findings in hematology and oncology.
Read More
